scholarly journals High-risk percutaneous coronary intervention with Impella CP hemodynamic support. A case series and method presentation

2017 ◽  
Vol 1 ◽  
pp. 67-71
Author(s):  
Adam Sukiennik ◽  
Michał Kasprzak ◽  
Wiesław Mazurek ◽  
Piotr Niezgoda ◽  
Łukasz Bednarczyk ◽  
...  
Keyword(s):  
Percutaneous Coronary Intervention ◽  
High Risk ◽  
Case Series ◽  
Coronary Intervention ◽  
Hemodynamic Support ◽  
Percutaneous Coronary

Outcome of Impella 2.5 use in patients undergoing Percutaneous Coronary Intervention in Henan, China: a case series

Perfusion ◽  
2021 ◽  
pp. 026765912110490
Author(s):  
Rafiq Ahmed Bhat ◽  
Syed Manzoor Ali ◽  
Akanksha Rathi ◽  
Javaid Akhter Bhat ◽  
Raja Saqib Iqbal ◽  
...  
Keyword(s):  
Heart Failure ◽  
Percutaneous Coronary Intervention ◽  
High Risk ◽  
Cardiogenic Shock ◽  
Case Series ◽  
Coronary Intervention ◽  
Left Ventricular ◽  
Hemodynamic Support ◽  
Percutaneous Coronary ◽  
Case Number

Background: Acute myocardial infarction (AMI) complicated by cardiogenic shock (AMI-CS) or heart failure is associated with an unacceptably high in-hospital mortality of 33%–55% and a lost chance to accept PCI (Percutaneous Coronary Intervention). Aim: The aim of the study was to find out whether percutaneous hemodynamic support device Impella 2.5 improves prognosis of high-risk PCI patients or not. Methods: This study was a case series involving six patients who underwent a Left Ventricular Assist Device (LVAD, Impella 2.5, Abiomed, Danvers, MA) implantation after suffering from AMI with a very low ejection fraction and acute heart failure. The clinical experience and outcomes of the patients are hereby discussed. Results: All PCI procedures were safely completed under LVAD support. The hemodynamic parameters of all patients improved clinically over the next 30 days and following 12 months after Impella insertion except in two patients, of which one patient (Case number 6) died 4 days post-Impella protected PCI procedure due to acute left ventricle heart failure with cardiogenic shock and pulmonary oedema; and another one died at 12 months after Impella protected PCI procedure (Case number 4) due to decompensated heart failure and infected pneumonia. Conclusion: Percutaneous hemodynamic support is favorable and feasible during high risk Percutaneous Coronary Intervention (PCI). A bigger study is needed to substantiate the claims of the current study.

Use of the Impella 2.5 in High-Risk Percutaneous Coronary Intervention

2011 ◽  
Vol 31 (1) ◽  
pp. e1-e16 ◽  
Author(s):  
Brenda McCulloch
Keyword(s):  
Percutaneous Coronary Intervention ◽  
High Risk ◽  
Interventional Procedures ◽  
Balloon Catheter ◽  
Limb Ischemia ◽  
Coronary Intervention ◽  
Assist Device ◽  
Hemodynamic Support ◽  
Multidisciplinary Program ◽  
Percutaneous Coronary

The Impella 2.5 is a percutaneously placed partial circulatory assist device that is increasingly being used in high-risk coronary interventional procedures to provide hemodynamic support. The Impella 2.5 is able to unload the left ventricle rapidly and effectively and increase cardiac output more than an intra-aortic balloon catheter can. Potential complications include bleeding, limb ischemia, hemolysis, and infection. One community hospital’s approach to establishing a multidisciplinary program for use of the Impella 2.5 is described.

scholarly journals Management of anti-thrombotic therapy in patients with recent percutaneous coronary intervention and acute dengue infection: A case series

2019 ◽  
Vol 28 (4) ◽  
pp. 284-287
Author(s):  
Wishnu Aditya ◽  
Jonathan Yap ◽  
Piotr Chlebicki ◽  
Charles Wah Hak Chan ◽  
Jack Wei Chieh Tan
Keyword(s):  
Percutaneous Coronary Intervention ◽  
High Risk ◽  
Dengue Infection ◽  
Case Series ◽  
Coronary Intervention ◽  
Careful Consideration ◽  
Risk Of Bleeding ◽  
Anti Platelet Therapy ◽  
Percutaneous Coronary ◽  
The Ideal

There is currently little data regarding the ideal management for a patient who has undergone recent percutaneous coronary intervention (PCI) and subsequently develops dengue fever. Patients with recent PCI are at high risk of stent thrombosis with cessation of dual anti-platelet therapy. On the other hand, patients with dengue viral infection are at high risk of bleeding. Managing patients with recent PCI and dengue involves the delicate balancing of the risk of thrombosis and bleeding. Careful consideration of the timing of coronary intervention and the severity of the dengue infection is required. We describe the management of the anti-thrombotic therapy in three different patients with dengue infection and recent PCI and discuss our approach to managing such patients.

scholarly journals The Role of Hemodynamic Support in High-risk Percutaneous Coronary Intervention

2020 ◽  
Vol 14 ◽  
Author(s):  
Charles Simonton ◽  
Craig Thompson ◽  
Jason R Wollmuth ◽  
D Lynn Morris ◽  
Thom G Dahle
Keyword(s):  
Percutaneous Coronary Intervention ◽  
High Risk ◽  
Heart Function ◽  
Coronary Intervention ◽  
Special Focus ◽  
Centrifugal Pumps ◽  
Hemodynamic Support ◽  
Improved Outcomes ◽  
Percutaneous Coronary ◽  
Support Devices

Patients with advanced age, complex coronary anatomy, and multiple comorbidities are often unsuitable for surgical revascularization. In this setting, hemodynamic support devices are used as an adjunct to percutaneous coronary intervention to maintain hemodynamic stability and enable optimal revascularization. This article provides an overview of percutaneous hemodynamic support devices currently used in clinical practice for high-risk percutaneous coronary intervention. These include the intra-aortic balloon pump, centrifugal pumps (TandemHeart, venous arterial extracorporeal membrane oxygenation), and micro-axial Impella pump. The hemodynamic effects, clinical evidence supporting improved outcomes and recovery of heart function, and associated complications with these devices are highlighted, with a special focus on Impella pumps.

Sign in / Sign up

Export Citation Format

Share Document